Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
LAT4 drives temozolomide induced radiotherapy resistance in glioblastoma by enhancing mTOR pathway activation
Wenrui Zang
Yangwu Liu
Jiajun Zheng
Yifeng Huang
Lei Chen
Chiyang Li
Jiakun Zhao
Qiang Zhou
Yangheng Xu
Zhenyuan Wang
Yongfu Cao
Wanling Zhang
Junjie Li
Yuntao Lu
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1186/s12935-024-03590-0
Dec 18, 2024
Version published to 10.21203/rs.3.rs-4913708/v1 on Research Square
Oct 14, 2024
Related articles
RFC4 Drives Temozolomide Resistance in Glioblastoma by Activating STK38-BECN1-Dependent Autophagy
This article has 9 authors:
Yan Wang
Min Mao
Ji Hang
Wenqian Yu
Qu-Jing Gai
Sen-lin Xu
Meng-Li Zhu
Xi He
Xin Wang
Mechanisms of induced resistance to the antitumoral agent ZZW-115 in pancreas ductal adenocarcinoma
This article has 9 authors:
Patricia Santofimia-Castaño
Wenjun Lan
Matias Estares
Yi Xia
Emma Cosialls
Nicolas Fraunhoffer
Ling Peng
Eduardo Chuluyan
Juan Iovanna
Integrated genetic screening reveals FEN1 as a driver of stemness and temozolomide resistance in glioblastoma
This article has 23 authors:
Benjamin A. Brakel
Dillon McKenna
Anish Puri
Vaseem Muhammad Shaikh
Manoj Singh
Ali Saleh
Abdo-jose Tomajian
Nicholas Mikolajewicz
Marcello Beltrami
Alisha Anand
Petar Miletic
Kevin R. Brown
David Tieu
William Maich
Sabra Salim
Yujin Suk
Minomi Subapanditha
Deena M.A. Gendoo
Chitra Venugopal
Jason Moffat
Sachin Katyal
Chirayu R. Chokshi
Sheila K. Singh
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up